What is the current valuation of the US varicose veins-treatment market?

The market valuation was $791.0 Million in 2024. Read More

What is the projected market valuation for the US varicose veins-treatment market by 2035?

The projected valuation for 2035 is $1301.36 Million. Read More

What is the expected CAGR for the US varicose veins-treatment market during the forecast period 2025 - 2035?

The expected CAGR during this period is 4.63%. Read More

Which treatment types are leading in the US varicose veins-treatment market?

Leading treatment types include Endovenous Laser Treatment at $200.0 - $350.0 Million and Surgical Ligation at $228.0 - $356.36 Million. Read More

What are the key procedure types in the US varicose veins-treatment market?

Key procedure types include Minimally Invasive procedures valued at $300.0 - $500.0 Million. Read More

Who are the major players in the US varicose veins-treatment market?

Major players include Medtronic, Boston Scientific, and Abbott Laboratories. Read More

What is the market size for different age groups in the US varicose veins-treatment market?

The market size for adults is $400.0 - $650.0 Million, while for the elderly, it is $300.0 - $550.0 Million. Read More

What is the market valuation for end users in the US varicose veins-treatment market?

Hospitals represent a market valuation of $300.0 - $500.0 Million. Read More

How does the market for ambulatory surgical centers compare to specialty clinics?

Ambulatory Surgical Centers are valued at $200.0 - $350.0 Million, whereas Specialty Clinics are valued at $150.0 - $250.0 Million. Read More

What trends are expected in the US varicose veins-treatment market by 2035?

The market is likely to experience growth driven by advancements in treatment technologies and increasing awareness. Read More

US Varicose Veins Treatment Market

ID: MRFR/Pharma/15202-HCR

100 Pages

Satyendra Maurya

Last Updated: April 06, 2026

United States Varicose Veins Treatment Market Research Report: Size, Share, Trend Analysis - Growth & Industry Forecast 2025 To 2035

US Varicose Veins Treatment Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)4.63%

2024 Market Size$ 791 Million

2025 Market Size$ 827.62 Million

2035 Market Size$ 1,301.36 Million

Key Players

Medtronic

Boston Scientific

Abbott Laboratories

B. Braun Melsungen AG

Cook Medical

Teleflex Incorporated

Trends

Rise of Minimally Invasive Techniques
Increased Focus on Patient Education
Growth of Telemedicine Services

Opportunities

Increase in Obesity Rates
Rising Awareness of Venous Health
Aging Population and Varicose Veins

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Chemicals and Materials, BY Treatment Type (USD Million)
  1. 4.1.1 Sclerotherapy
  2. 4.1.2 Laser Therapy
  3. 4.1.3 Endovenous Laser Treatment
  4. 4.1.4 Radiofrequency Ablation
  5. 4.1.5 Surgical Ligation
2. 4.2 Chemicals and Materials, BY Procedure Type (USD Million)
  1. 4.2.1 Minimally Invasive
  2. 4.2.2 Surgical
  3. 4.2.3 Ambulatory
3. 4.3 Chemicals and Materials, BY End User (USD Million)
  1. 4.3.1 Hospitals
  2. 4.3.2 Ambulatory Surgical Centers
  3. 4.3.3 Specialty Clinics
  4. 4.3.4 Home Healthcare
4. 4.4 Chemicals and Materials, BY Age Group (USD Million)
  1. 4.4.1 Adults
  2. 4.4.2 Elderly
  3. 4.4.3 Pediatric
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Chemicals and Materials
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Medtronic (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Boston Scientific (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Abbott Laboratories (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 B. Braun Melsungen AG (DE)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Cook Medical (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Teleflex Incorporated (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Stryker Corporation (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 AngioDynamics (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY TREATMENT TYPE
3. 6.3 US MARKET ANALYSIS BY PROCEDURE TYPE
4. 6.4 US MARKET ANALYSIS BY END USER
5. 6.5 US MARKET ANALYSIS BY AGE GROUP
6. 6.6 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF CHEMICALS AND MATERIALS
9. 6.9 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
10. 6.10 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
11. 6.11 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
12. 6.12 CHEMICALS AND MATERIALS, BY TREATMENT TYPE, 2024 (% SHARE)
13. 6.13 CHEMICALS AND MATERIALS, BY TREATMENT TYPE, 2024 TO 2035 (USD Million)
14. 6.14 CHEMICALS AND MATERIALS, BY PROCEDURE TYPE, 2024 (% SHARE)
15. 6.15 CHEMICALS AND MATERIALS, BY PROCEDURE TYPE, 2024 TO 2035 (USD Million)
16. 6.16 CHEMICALS AND MATERIALS, BY END USER, 2024 (% SHARE)
17. 6.17 CHEMICALS AND MATERIALS, BY END USER, 2024 TO 2035 (USD Million)
18. 6.18 CHEMICALS AND MATERIALS, BY AGE GROUP, 2024 (% SHARE)
19. 6.19 CHEMICALS AND MATERIALS, BY AGE GROUP, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TREATMENT TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY PROCEDURE TYPE, 2025-2035 (USD Million)
  3. 7.2.3 BY END USER, 2025-2035 (USD Million)
  4. 7.2.4 BY AGE GROUP, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Chemicals and Materials Market Segmentation

Chemicals and Materials By Treatment Type (USD Million, 2025-2035)

Sclerotherapy
Laser Therapy
Endovenous Laser Treatment
Radiofrequency Ablation
Surgical Ligation

Chemicals and Materials By Procedure Type (USD Million, 2025-2035)

Minimally Invasive
Surgical
Ambulatory

Chemicals and Materials By End User (USD Million, 2025-2035)

Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Home US Varicose Veins Treatment Market

Chemicals and Materials By Age Group (USD Million, 2025-2035)

Adults
Elderly
Pediatric

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”